Mark Baldry

CIK: 0001644137

Transaction Breakdown

Open Market Buys (P)3 (33.3%)

High conviction signal

Open Market Sales (S)2 (22.2%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)4 (44.4%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

XFOR

X4 Pharmaceuticals, Inc

Officer

Discretionary Trading P&L

Holdings

Transaction History (9 total)

XFOR
X4 Pharmaceuticals, Inc
May 16, 2025
Award(A)
Direct
1K shares at avg. $2.48$3K
XFOR
X4 Pharmaceuticals, Inc
May 16, 2025
Purchase(P)
Direct
1K shares at avg. $2.48$3K
XFOR
X4 Pharmaceuticals, Inc
Feb 12, 2025
Award(A)
Direct
600K shares-
XFOR
X4 Pharmaceuticals, Inc
Jan 24, 2025
Sale(S)
Direct
29.2K shares at avg. $0.45$13K
XFOR
X4 Pharmaceuticals, Inc
Jan 23, 2025
Award(A)
Direct
74.8K shares-
XFOR
X4 Pharmaceuticals, Inc
Nov 15, 2024
Purchase(P)
Direct
13.4K shares at avg. $0.34$5K
XFOR
X4 Pharmaceuticals, Inc
Oct 7, 2024
Sale(S)
Direct
11.1K shares at avg. $0.58$7K
XFOR
X4 Pharmaceuticals, Inc
Oct 4, 2024
Award(A)
Direct
34.9K shares-
XFOR
X4 Pharmaceuticals, Inc
May 17, 2024
Purchase(P)
Direct
21.6K shares at avg. $0.68$15K

		Type	Shares	Price		Ownership
May 16, 2025	XFOR X4 Pharmaceuticals, Inc	Award(A)	1,032	$2.48	$2,561	Direct
May 16, 2025	XFOR X4 Pharmaceuticals, Inc	Purchase(P)	1,032	$2.48	$2,561	Direct
Feb 12, 2025	XFOR X4 Pharmaceuticals, Inc	Award(A)	600,000	-	-	Direct
Jan 24, 2025	XFOR X4 Pharmaceuticals, Inc	Sale(S)	29,159	$0.45	$13,241	Direct
Jan 23, 2025	XFOR X4 Pharmaceuticals, Inc	Award(A)	74,773	-	$0	Direct
Nov 15, 2024	XFOR X4 Pharmaceuticals, Inc	Purchase(P)	13,404	$0.34	$4,598	Direct
Oct 7, 2024	XFOR X4 Pharmaceuticals, Inc	Sale(S)	11,127	$0.58	$6,506	Direct
Oct 4, 2024	XFOR X4 Pharmaceuticals, Inc	Award(A)	34,946	-	$0	Direct
May 17, 2024	XFOR X4 Pharmaceuticals, Inc	Purchase(P)	21,646	$0.68	$14,654	Direct

1-9 of 9 transactions

About Baldry Mark

Baldry Mark (SEC CIK 0001644137) files insider reports with the SEC as Chief Commercial Officer of X4 Pharmaceuticals, Inc (XFOR).

Signal8 holds 5 ownership filings by Baldry Mark, all Form 4s, filed between Oct 8, 2024 and Jun 3, 2025. Those filings report 9 transactions, from May 17, 2024 to May 16, 2025. Signal8's Form 4 history starts in Sep 2024.

The business address on Baldry Mark's filings is in BOSTON, MA.

Recent filings by Baldry Mark

May 16, 2025: Grant or award of XFOR shares (Form 4, code A).
May 16, 2025: Open-market purchase of XFOR shares (Form 4, code P).
Feb 12, 2025: Grant or award of XFOR shares (Form 4, code A).
Jan 24, 2025: Open-market sale of XFOR shares (Form 4, code S).
Jan 23, 2025: Grant or award of XFOR shares (Form 4, code A).

Other insiders filing for X4 Pharmaceuticals, Inc (XFOR)

Craig Adam R, Executive Chairman
KIRSKE DAVID, Chief Financial Officer
Volpone John, President
Gold Kelly, Director
Bridger Gary, Director
de Craecker Francoise, Director

How to read Form 4 transaction codes